| 000 | 01201 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513051347.0 | ||
| 264 | 0 | _c19940606 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a0304-3940 | ||
| 024 | 7 |
_a10.1016/0304-3940(94)91020-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHassel, B | |
| 245 | 0 | 0 |
_aNeurotoxicity of albumin in vivo. _h[electronic resource] |
| 260 |
_bNeuroscience letters _cFeb 1994 |
||
| 300 |
_a29-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aGlutamates _xadverse effects |
| 650 | 0 | 4 | _aGlutamic Acid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNervous System _xdrug effects |
| 650 | 0 | 4 |
_aNervous System Diseases _xchemically induced |
| 650 | 0 | 4 | _aOsmolar Concentration |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSerum Albumin _xadverse effects |
| 700 | 1 | _aIversen, E G | |
| 700 | 1 | _aFonnum, F | |
| 773 | 0 |
_tNeuroscience letters _gvol. 167 _gno. 1-2 _gp. 29-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0304-3940(94)91020-0 _zAvailable from publisher's website |
| 999 |
_c7909264 _d7909264 |
||